Asepsis announces the USPTO grant of U.S. Patent 9,302,050 for its combinatorial, Calibrated Drug Delivery™ (CDD) platform. The 050 patent continuation further enhances the reconstitution aspects of t
Asepsis announces the USPTO grant of U.S. Patent 9,302,050 for its combinatorial, Calibrated Drug Delivery™ (CDD) platform. The 050 patent continuation further enhances the reconstitution aspects of t